Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes

clinical trial

Details

Instance of: clinical trial
Start time: 18 April 2017
End time: April 2022
Country: Norway
Main subject: type-1 diabetes, diabetes
clinical trial phase: phase IV clinical trial
maximum age: 95
minimum age: 2
number of participants: 30
short name: SUtoChildT1D
study type: interventional study
title: Switching From Insulin to Sulfonylurea in Childhood and Adult Diabetes Due to Variants in the HNF1A, HNF4A, or HNF1B Genes

Nothing in the MetaHistoryBook collection references this item yet.